SUSAN RIVAS: Open Payments
NPI 1801928510 · HOWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 10 payments from 7 companies in 2025. Trend: 2023 $74 · 2024 $208 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Corcept Therapeutics | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Biogen, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: AIRSUPRA, Korlym, Kerendia, MOUNJARO, EVKEEZA, SPINRAZA, CAPVAXIVE, BREZTRI.
Industry payments across NJ — which companies pay providers there.
